Introduction
The Ohio State University Pelotonia Research Center stands at the forefront of cancer research in the United States. Located on the Columbus campus, the center brings together scientists, clinicians, and students to accelerate discoveries that can be turned into real‑world treatments. By integrating laboratory science with patient‑focused care, the center embodies Ohio State’s commitment to improving health outcomes for individuals and families affected by cancer.
Mission and Vision
Ohio State’s Pelotonia Research Center pursues a clear mission: to advance knowledge of cancer biology, develop innovative therapies, and translate those breakthroughs into better patient care. The vision is to become a globally recognized hub where cutting‑edge research meets compassionate clinical practice, offering hope to those confronting a cancer diagnosis.
Core Research Areas
Research at the center is organized around several high‑impact themes, each designed to address unanswered questions in oncology.
- Cancer Genetics – Investigators map genetic mutations that drive tumor growth, using next‑generation sequencing to identify targets for precision drugs.
- Immunotherapy – Teams develop checkpoint inhibitors, CAR‑T cells, and vaccine strategies that empower the immune system to recognize and destroy cancer cells.
- Precision Medicine – By integrating genomic data with clinical information, researchers tailor treatment plans to the unique molecular profile of each patient.
- Cancer Stem Cells – Studies explore how a small subpopulation of cells sustains tumor recurrence and resistance, seeking ways to eradicate these “root” cells.
Funding for Cancer Research
Robust financial support fuels the center’s work. The primary source is the Pelotonia Fund, created by the late Dr. James and Kathryn Pelot, which channels community donations directly into innovative projects. Additional funding comes from the National Cancer Institute (NCI), federal grants, and partnerships with industry leaders. This diversified portfolio ensures long‑term stability and the ability to pursue high‑risk, high‑reward science.
State‑of‑the‑Art Facilities
Ohio State’s investment in infrastructure gives researchers the tools they need to move discoveries from bench to bedside quickly.
- Advanced Imaging Suite – MRI, PET/CT, and optical imaging platforms provide real‑time visualization of tumor biology and treatment response.
- High‑Content Screening Core – Automated robotics test thousands of compounds per day, accelerating the identification of promising drug candidates.
- Translational Laboratories – Equipped for cell culture, CRISPR editing, and organoid development, these labs bridge basic science and clinical trials.
Collaboration and Partnerships
Collaboration is a cornerstone of the Pelotonia Research Center’s strategy. The center works closely with:
- Ohio State University Comprehensive Cancer Center – Joint clinical trials and shared patient registries enhance the speed at which new therapies reach patients.
- National Cancer Institute – Cooperative agreements enable multi‑institution studies that address national research priorities.
- Industry Partners – Pharmaceutical and biotech companies provide expertise in drug development, regulatory pathways, and commercialization.
Pending Approval by The Board of Trustees
Pending approval by The Ohio State University Board of Trustees, the center plans a major expansion that will add:
- New faculty positions to attract top talent in immunology and genomics.
- A dedicated patient‑derived xenograft facility for testing therapies in models that closely mimic human tumors.
- Expanded community outreach programs that educate the public about cancer prevention and clinical trial participation.
These initiatives are expected to increase research output, enhance training opportunities for graduate students, and deepen the center’s impact on regional health.
Thank You to Our Supporters
Thank you to the Pelotonia Fund donors, alumni, corporate partners, and the many volunteers who make this work possible. Their generosity creates a pipeline of resources that fuels discovery, supports early‑career investigators, and ultimately brings new hope to patients.
Community Impact and Education
Beyond research, the Pelotonia Research Center engages the Columbus community through:
- Public seminars that translate complex science into understandable information.
- Student mentorship programs that inspire the next generation of scientists and clinicians.
- Screening events and health fairs that promote early detection and prevention.
Future Directions
Looking ahead, the center will focus on three strategic priorities:
- Accelerating Clinical Translation – Streamlining the pathway from laboratory discovery to clinical trial enrollment.
- Expanding Precision Oncology – Integrating multi‑omics data (genomics, proteomics, metabolomics) to refine patient‑specific treatment algorithms.
- Strengthening Diversity in Research – Recruiting a diverse workforce and ensuring clinical studies reflect the demographics of Ohio’s population.
Conclusion
The Ohio State University Pelotonia Research Center exemplifies how a university, a philanthropic community, and a dedicated research team can unite to confront one of the most challenging diseases of our time. With strong funding for cancer research, cutting‑edge facilities, and a collaborative spirit, the center is poised to make lasting contributions to science and patient care. As new discoveries emerge and the pending expansion moves forward, the center will continue to offer hope, innovation, and healing to countless individuals facing cancer.
